Briumvi 73150-0150

Generic: Ublituximab

Product NDC

73150-0150

Manufacturer: Tg Therapeutics, Inc.
Dosage Form: Injection, Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: December 28, 2022
Listing Expires: December 31, 2027
Application: BLA761238

Need to source Briumvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ublituximab	150 mg/6mL

Drug Class

CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]

Packaging Options(1)

73150-0150-06

1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE

View →